Corporate Governance

Mark Thierer has served as an advisor to Foresight since October 2020. Mr. Thierer currently serves as the managing partner of the investment firm he formed, AssetBlue Investment Group, a position he has held since June 2017. From October 2017 through February 2018, Mr. Thierer also served as the interim Chief Executive Officer of Dentsply Sirona Inc. (NASDAQ: XRAY), a manufacturer of dental implants. Mr. Thierer was Chief Executive Officer of OptumRx, a pharmacy care services company, from July 2015 until September 2017. He previously served as chairman and Chief Executive Officer of Catamaran Corporation (NASDAQ: CTRX), one of the nation’s largest pharmacy benefit management companies, from March 2011 until it combined with OptumRx in 2015. Mr. Thierer has experience as a Chief Executive Officer leading a national pharmacy benefit and healthcare information technology solutions company. His skills include strategy and business development, technology, finance and marketing. He brings valuable leadership experience and knowledge of operations and the day-to-day management of a national corporation. Mr. Thierer also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions. Mr. Thierer is a member of the board of directors of Discover Financial Services (NYSE: DFS) since 2014 and Senior Connect Acquisition Corp. (NASDAQ: SNRH). Mr. Thierer received a BS in Finance from the University of Minnesota and an MBA from Nova Southeastern University. Mr. Thierer also holds the designation of CEBS (Certified Employee Benefits Specialist) from The Wharton School of the University of Pennsylvania. Mr. Thierer was selected to serve on our Board for his extensive experience in both the financial and healthcare sectors.

Dr. Sherif Abdou has focused his 30-year career on managing and leading the transformation of the health care delivery system throughout the United States. A highly respected healthcare professional known for his forward-thinking efforts in business strategy development, patient care and network expansion, he currently leads the patient-centered, physician led and population health focused healthcare company he co-founded in 2015.

Dr. Abdou guides all aspects of company operations, reducing costs and improving medical outcomes through data-driven strategies. Regarded as a pioneer in coordinated care, Dr. Abdou has successfully integrated specialty providers into primary care networks while improving physician engagement, creating a winning culture, and developing financial models to incentivize patient-focused objectives.

As part of a 15-month P3 consulting agreement, Dr. Abdou led Ascension Medical Group as its CEO where he transformed a disparate hospital-owned physician group with 7,500 physicians in 23 states into a high-performing medical group. He fostered a culture of excellence dedicated to successful health outcomes through improved care experiences for both physicians and patients, while conserving costs.

Dr. Abdou held various leadership positions with DaVita HealthCare Partners, Inc. (NYSE: DVA). where he developed and led HealthCare Partners Nevada (HCPNV) where he facilitated expanded the five-clinic group to a comprehensive organization with 52 medical clinics, more than 1,700 specialists, and 310 primary care providers serving 300,000 patients each year. He guided the organization’s efforts to expand its Medicare Advantage population by nearly 700 percent from 2006 to 2014. He also led the company’s strategic acquisitions while improving quality metrics and earning a four-star rating from the Centers for Medicare & Medicaid Services. In his role as Desert Region President for DaVita HealthCare Partners, he formulated in-depth strategies to expand the company’s commercial and Medicare patient populations in Arizona, Nevada and New Mexico.

In 1999, Dr. Abdou founded Summit Medical Group, where he developed an innovative, coordinated approach to health care in Southern Nevada. He successfully guided the company through an acquisition to become Pinnacle Health System, which later became HCPNV. During his tenure as the President of Physician IPA, he formed the Inpatient Physicians Network, the first organized hospitalist company in the state of Nevada, and secured the nation’s first population health capitated contract for hospitalists. P5 became the nation’s second-largest third-party administrator under his presidency.

Prior to leading these prominent medical organizations, Dr. Abdou worked as a hospitalist and primary care physician for Desert Springs Hospital Medical Center in Las Vegas. He also served as a clinical research fellow at the University of Southern California.

He earned his Doctor of Medicine degree from Mansoura University School of Medicine, later completing an internship at the institution. He also completed an internship in internal medicine and a hospital residency at University Medical Center in Las Vegas. Dr. Abdou was certified by the American Board of Internal Medicine in 1995 and completed his master’s degree in medical management from the University of Southern California in 2003. He is a member of Cigna’s Accountable Care Organization National Council and the Nevada Association of Managed Care Physicians. He is a fellow of the American College of Physicians and the American College of Physician Executives.

With 23 years of experience in operating, managing, and guiding physician groups, Dr. Amir Bacchus, engages providers to succeed in a dynamic healthcare landscape. Much of his career has focused on healthcare delivery and working with managed care organizations to promote improved quality, access, and cost of care through quality and performance metrics.

As the Chief Medical Officer and P3 Health Partner’s co-founder, his unwavering passion for medicine fosters P3’s culture where clinical engagement and aligned incentives prioritize quality, utilization, and customer satisfaction.

Through a P3 consulting agreement, Dr. Bacchus recently served as the Chief Medical Officer for Ascension Medical Group. There, he engaged directly with 7,500 physicians in 23 states to lead the organization’s efforts to move from a fee-for-service model to managing patient risk portfolios.

Prior to founding P3, Dr. Bacchus served as the Chief Medical Officer and Co-Founder of HealthCare Partners (HCP) Desert Region as well as the company’s National Corporate Medical Director. In this role, he oversaw all aspects of care for the organization’s medical group, IPA network, and care management teams. He led, mentored, and educated all providers on the organization’s innovative, value-based approach to medicine. He guided the company’s clinical leaders and medical directors to support HCP’s patient-focused mission and best practices.

Dr. Bacchus was also the Co-Founder and Chief Medical Officer of Pinnacle Health System where he built a medical group and a national hospitalist group, Inpatient Physicians Network, and the independent physician association (IPA), which became the sole delivery system for PacifiCare/Secure Horizons and other health plans before it was purchased by HCP.

As the Chief Executive Officer and Managing Partner of Diagnostic Center of Medicine in Las Vegas, he led a 27-primary care physician practice at five Las Vegas offices. Prior to taking on a leadership role with Diagnostic Center of Medicine, he worked as an internist for the company, providing primary care and inpatient/outpatient management with a significant intensive care unit workload.

Dr. Bacchus served as the Chairman of Spring Valley Hospital Medical Center’s Department of Medicine and he is a member of the University of Nevada, Las Vegas School of Medicine Community Advisory Board. He is certified by the American Board of Internal Medicine and is a member of the American Medical Association, Clark County Medical Society, the American College of Physicians and the Society of Hospital Medicine. He also founded the Nevada Regional Chapter of the Society of Hospital Medicine.

Dr. Bacchus received his Doctor of Medicine degree from Wayne State University School of Medicine. He completed his residency at St. John Hospital and Medical Center in Detroit, where he was named Resident of the Year for both1993-94 and 1995-96. In 2003, he received a Master of Business Administration from the University of Nevada, Las Vegas. Dr. Bacchus has also been recognized by Las Vegas Life Magazine as one of the best doctors in Las Vegas.

Greg Wasson has served as a director of Foresight and chairman of the board of directors since November 2020. Mr. Wasson currently serves as President and Founder of his own family office, Wasson Enterprise. Wasson Enterprise’s focus is to partner with entrepreneurs and operators to build sustainable, high-growth businesses that do well by doing good. As the former President and CEO of Walgreens Boots Alliance, Inc., Mr. Wasson has extensive global operational and management experience, as well as extensive knowledge of the retail and healthcare industries. Mr. Wasson attended Purdue University’s School of Pharmacy, receiving his pharmacy degree in 1981. Before his senior year, he was invited to become one of the first pharmacy services interns in Walgreens’ corporate offices—an opportunity that led to his being hired by Walgreens upon graduation and that changed the course of his future career. Mentored by many company leaders through the years, together with his outstanding performance in positions of increasing responsibility, Mr. Wasson served Walgreens for 34 years. As Walgreens CEO, Mr. Wasson led the Fortune 35 company to record fiscal 2014 sales of $76.4 billion. He is credited with creating significant financial and shareholder value, initiating and completing transformative mergers and investments, leading complex organizational and structural change, assembling a diverse and high- performance senior leadership team, and establishing Walgreens’ position as an industry leader. Before retiring from Walgreens, Mr. Wasson had transformed an iconic 114-year-old domestic company into the first global pharmacy-led, health, well-being and beauty enterprise via the successful merger with European-based Alliance Boots to create Walgreens Boots Alliance, Inc. Mr. Wasson currently serves on the Board of Directors of OptimizeRx Corp. (NASDAQ: OPRX) since August 2020. Mr. Wasson also served on the Board of Directors of PNC Financial Services Group, Inc. (NYSE: PNC) from July 2015 to October 2018 and Verizon Communications Inc. (NYSE: VZ) from February 2013 to October 2018.

Lawrence B. Leisure has served on the board of managers of P3 since April 2017. Mr. Leisure currently serves as a director of BioIntelliSense, a position he has held since January 2019, a director of Xsell Technology, a position he has held since December 2015, and a director of HIMSS (not for profit), a position he has held since January 2019. Mr. Leisure also served as a director of MyGrove, from January 2012 to June 2021. Mr. Leisure currently serves as a manager of Recovery Ways Holdings, a position he has held since July 2014, a manager of Sage Veterinary Partners, LLC, a position he has held since July 2018, a manager of Pinnacle Dermatology Holdings, LLC, a position he has held since February 2017, a manager of Chicago Pacific Capital, L.P., a position he has held since July 2014, a manager of Chicago Pacific Founders UGP I, a position he has held since July 2014, a manager of Chicago Pacific Founders UPP II, a position he has held since June 2019, a manager of Wellbe Senior Medical, LLC, a position he has held since March 2019, a manager of Impact Advisors Holdings, LLC, a position he has held since December 2019, and a manager of Allymar Health Solutions, LLC, a position he has held since March 2021. Mr. Leisure also served as a manager of FEMG Holdings, LLC, from August 2018 to July 2021. Mr. Leisure received a Bachelor of Arts degree from Stanford University and an MBA degree from the University of California, Los Angeles. Mr. Leisure was selected to serve on our Board for his deep experience in value based healthcare delivery models and broad industry relationships.

Mary Tolan has served on the board of managers of P3 since April 2017. Ms. Tolan currently serves as a director of Tredence, Inc., a position she has held since November 2020. Ms. Tolan served as a director of Atrio Health Plan, Inc. from June 2019 to July 2021. Ms. Tolan co-founded and serves as Managing Partner of Chicago Pacific Founders, a private equity fund focused exclusively on healthcare services. Previously, Ms. Tolan was the founder of Accretive Health (now R1 RCM, Inc. (NASDAQ: RCM)), a provider of comprehensive end-to-end healthcare revenue-cycle management services and population health management services infrastructure. Ms. Tolan served as Accretive Health’s Chief Executive Officer from November 2003 to April 2013 and served as Board Chair of Accretive Health until November 2013. Prior to Accretive Health, Ms. Tolan was a Group Chief Executive at Accenture, the global management consulting, technology services, and outsourcing company. Ms. Tolan serves on the Boards of Trustees for the University of Chicago and Loyola University. Ms. Tolan received a Bachelor of Business Administration degree from Loyola University and an MBA from the University of Chicago. Ms. Tolan was selected to serve on our Board for her experience as an executive in the healthcare services industry and her investing experience.

Greg Kazarian has served on the board of managers of P3 since May 2018. Mr. Kazarian currently serves as a director of Recovery Ways Holdings, LLC, a position he has held since July 2014, and a director of CPF Outpatient Holdings, LLC, a position he has held since October 2020. Mr. Kazarian is a Founding Operating Partner of Chicago Pacific Founders. Mr. Kazarian served as the Chief Executive Officer of Recover Ways Holdings, LLC, from May 2018 to August 2020. Mr. Kazarian was one of the four Executive Officers of Accretive Health (now R1 RCM, Inc. (NASDAQ: RCM)) a provider of comprehensive end-to-end healthcare revenue-cycle management services and population health management services infrastructure. Mr. Kazarian served in a variety of roles during his tenure at Accretive Health including General Counsel, Head of the Physician Advisory Services Business and Senior Vice President of Operations with P&L responsibility for one third of the Company’s revenue cycle business. Prior to joining Accretive Health, Mr. Kazarian was a partner at Pedersen and Houpt in Chicago, where he spent 16 years representing mid-sized growth companies. Mr. Kazarian received his law degree and his Bachelor of Science degree in Biophysics from the University of Illinois. Mr. Kazarian was selected to serve on our Board for his experience as an executive in the healthcare services industry and his investing experience.

Thomas E. Price, M.D. has served on the board of managers of P3 since January 2018. Dr. Price currently serves as a director of Sanuwave Health, Inc. (NASDAQ: SNWV), a position he has held since 2020, a director of HealthWiseFirst, LLC, a position he has held since 2018, a director of Association Health Plans of America, LLC, a position he has held since 2018, a director of Transformation Care Network, LLC, a position he has held since 2020, Botanicals Sciences, LLC, a position he has held since 2020, a director of Capital Ministries (non-profit), a position he has held since 2018, and a director of Georgia Research Alliance (non-profit), a position he has held since 2019. Dr. Price entered private medical practice in 1984, returned to Emory University as an assistant professor of orthopedic surgery in 2002 and subsequently serviced as director of the orthopedic clinic at Atlanta’s Grady Memorial Hospital. Dr. Price served in the US House of Representatives from Georgia’s 6th district from 2005 to 2017, during which time he served as Chair of the House Budget Committee from 2015 to 2017. In February 2017, he was confirmed by the Senate as the United States Secretary of Health and Human Services (HHS) and remained in that position until September 2017. Currently, Dr. Price serves on the boards of several privately held health care companies and non-profits as well as consulting and advising companies. Dr. Price holds Bachelor’s and Doctor of Medicine degrees from the University of Michigan. Dr. Price was selected to serve on our Board for his extensive experience in public service and medical practice that bring a deep perspective on P3’s business.

Jeffrey G. Park, has served since April 2019 as the Chairman and Chief Executive Officer of WellDyneRx, an independent pharmacy benefits manager. From January 2018 until May 2018, he was the Interim Chief Executive Officer of Diplomat Pharmacy, Inc., or Diplomat (NYSE: DPLO), a provider of specialty pharmacy services. Additionally, from June 2017 to February 2019, he served on the board of directors of Diplomat. Prior to that, from July 2015 until July 2016, he was the Chief Operating Officer of OptumRX, the entity resulting from the merger of Catamaran Corporation, or Catamaran, and OptumRX, UnitedHealthcare Group’s free-standing pharmacy care services business. Before the merger, from March 2014 until July 2015, he was Catamaran’s Executive Vice President, Operations, and previously served as Catamaran’s Chief Financial Officer, beginning in 2006. Mr. Park currently serves as a director of Progyny, Inc. (NASDAQ: PGNY), a position he has held since October 2019. Mr. Park holds a B.S. in Accounting from Brock University. Mr. Park was selected to serve on our Board for his extensive leadership experience in the pharmaceutical industry.